Assessing the Mechanisms and Impact of a Novel Cannabinoid Product for Gynecologic Pain

NCT07728695 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Endometriosis
Adenomyosis
Chronic Pelvic Inflammatory Disease

Interventions

DRUG: Custom-formulated, high-CBD study product
DRUG: Placebo

Sponsor

Staci Gruber, Ph.D.

Collaborators

[object Object]